📰 While Glenmark News
While Glenmark News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from While Glenmark. Real-time updates on events, politics, business and more.
December 23, 2020
Glenmark Pharmaceuticals and Menarini enter into Exclusive Licensing Agreement for commercializing Ryaltris™ Nasal Spray Posted On: 2020-12-22 20:36:41 (Time Zone: Arizona, USA) Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led global integrated pharmaceutical company, today announced that its Swiss subsidiary, Glenmark Specialty S.A., has entered into an exclusive licensing agreement with Menarini Group (Menarini) for commercializing its innovative nasal spray Ryaltris™ across ...
December 23, 2020
Glenmark Pharmaceuticals Ltd Glenmark Pharmaceuticals and Menarini enter into exclusive licensing agreement for commercializing Ryaltris™ nasal spray across numerous markets throughout Europe ANI | Updated: Dec 23, 2020 11:14 IST Mumbai (Maharashtra) [India] December 23 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd (Glenmark), a research-led global integrated pharmaceutical company, today announced that its Swiss subsidiary, Glenmark Specialty SA, has en...
December 23, 2020
Glenmark to commercialize Ryaltris⢠nasal spray throughout Europe Glenmark to commercialize Ryaltris⢠nasal spray throughout Europe 23 December 2020 | News Source credit: Shutterstock Glenmark Pharmaceuticals Ltd, a research-led global integrated pharmaceutical company, has announced that its Swiss subsidiary, Glenmark Specialty SA, has entered into an exclusive licensing agreement with Menarini Group (Menarini) for commercialising its innovative nasal spray Ryaltris™ across 33 cou...
December 23, 2020
Glenmark Pharmaceuticals and Menarini enter into Exclusive Licensing Agreement for commercializing MUMBAI, India, Dec 23, 2020 /PRNewswire/ -- Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led global integrated pharmaceutical company, today announced that its Swiss subsidiary, Glenmark Specialty S.A., has entered into an exclusive licensing agreement with Menarini Group (Menarini) for commercializing its innovative nasal spray Ryaltris™ across 33 countries in Europe, including t...
December 23, 2020
Glenmark inks pact with Menarini Group to commercialise nasal spray in Europe The companys product is a novel fixed-dose combination nasal spray of an antihistamine and a steroid, indicated for treatment of symptoms associated with seasonal allergic rhinitis (SAR) in patients over 12 years of age. PTI December 23, 2020 / 11:38 AM IST Glenmark Pharmaceuticals on Wednesday said its subsidiary has inked a licensing pact with Menarini Group for commer...
December 23, 2020
Glenmark Pharma ties up with Menarini for commercializing Ryaltris Nasal Spray Mumbai, Dec 23 (UNI) Pharma major, Glenmark Pharma on Wednesday said that its Swiss subsidiary, Glenmark Specialty S.A., has entered into an exclusive licensing agreement with Menarini Group (Menarini) for commercializing its innovative nasal spray Ryaltris across 33 countries in Europe, including the Balkan region. Ryaltris [olopatadine hydrochloride (665 mcg) and mometasone furoate (25 mcg)], developed by Glenmark...